On Monday, September 5, another meeting of the Transparency Council.
The agenda includes:
Preparation of a position on the legitimacy of granting consent for the reimbursement of the Tript-OH (oxitriptan) medicinal product in the indication: tetrahydrobiopterin deficits....
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
